tanshinone has been researched along with Alloxan Diabetes in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 10 (83.33) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Gajendran, B; Han, M; Hu, Q; Lu, D; Shen, X; Wang, S; Wu, S; Xu, Y; Zhang, J | 1 |
| Chen, X; Dai, D; Gao, Y; Ge, S; Kong, Y; Liu, Q; Lu, Z; Sun, D; Wang, F; Wang, N; Wu, R; Yang, Y | 1 |
| Gao, J; Liu, T; Qin, L; Shi, H; Wang, D; Wei, Y; Xu, T; Xu, Y | 1 |
| Guo, ZL; Kong, DW; Ri-Ge-le, A; Wang, Q; Yang, WQ; Yu, YB; Zhang, BJ; Zhang, L | 1 |
| Bi, Y; Chen, J; Chen, L; Xu, L; Zhang, Q | 1 |
| Feng, FB; Qiu, HY | 1 |
| Gao, G; Gong, B; Li, Q; Luo, S; Ma, L; Mei, W; Qi, W; Xu, L; Yang, X; Yang, Z; Zhao, Z; Zhou, L; Zhou, T | 1 |
| Chen, G; Li, C; Lin, Y; Meng, Y; Tang, S; Zhang, X | 1 |
| Chen, YD; Guo, XH; Li, YH; Xu, Q; Xu, WH; Zhang, S | 1 |
| Jung, KH; Kim, SK; Lee, BC | 1 |
| Cao, F; Du, J; Gao, H; Li, Y; Sun, D; Wang, H; Wei, L; Zhang, Y; Zhao, L | 1 |
| Cao, F; Li, J; Li, W; Shen, M; Sun, D; Wang, H; Yuan, Y; Zhang, Y; Zhang, Z; Zhao, L | 1 |
12 other study(ies) available for tanshinone and Alloxan Diabetes
| Article | Year |
|---|---|
Tanshinone IIA ameliorates experimental diabetic cardiomyopathy by inhibiting endoplasmic reticulum stress in cardiomyocytes via SIRT1.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Humans; Mice; Myocytes, Cardiac; Sirtuin 1 | 2023 |
Tanshinone IIA attenuates renal damage in STZ-induced diabetic rats via inhibiting oxidative stress and inflammation.
Topics: Abietanes; Albuminuria; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Inflammation; Inflammation Mediators; Kidney Function Tests; Male; Oxidative Stress; Rats | 2017 |
Tanshinone I alleviates insulin resistance in type 2 diabetes mellitus rats through IRS-1 pathway.
Topics: Abietanes; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Insulin Receptor Substrate Proteins; Insulin Resistance; Interleukin-6; Medicine, Chinese Traditional; NF-kappa B; Phosphorylation; Rats; Rats, Sprague-Dawley; Streptozocin; Tumor Necrosis Factor-alpha | 2017 |
Tanshinone IIA Improves Painful Diabetic Neuropathy by Suppressing the Expression and Activity of Voltage-Gated Sodium Channel in Rat Dorsal Root Ganglia.
Topics: Abietanes; Animals; Behavior, Animal; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Ganglia, Spinal; Male; Rats; Rats, Sprague-Dawley; Voltage-Gated Sodium Channels | 2018 |
Tanshinone IIA exerts neuroprotective effects on hippocampus-dependent cognitive impairments in diabetic rats by attenuating ER stress-induced apoptosis.
Topics: Abietanes; Animals; Apoptosis; Cognitive Dysfunction; Diabetes Mellitus, Experimental; Disease Models, Animal; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Heat-Shock Proteins; Hippocampus; Male; Malondialdehyde; Maze Learning; Neurons; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Streptozocin; Superoxide Dismutase; Transcription Factor CHOP | 2018 |
Neuroprotective effect of tanshinone IIA against neuropathic pain in diabetic rats through the Nrf2/ARE and NF-κB signaling pathways.
Topics: Abietanes; Animals; Diabetes Mellitus, Experimental; Male; Neuralgia; Neuroprotective Agents; NF-E2-Related Factor 2; NF-kappa B; Rats; Rats, Sprague-Dawley; Signal Transduction | 2018 |
TanshinoneⅡA phenanthroimidazole derivative polarizes macrophage to improve metabolic homeostasis.
Topics: Abietanes; Adipose Tissue; Animals; Anti-Obesity Agents; Blood Glucose; Body Weight; Cell Differentiation; Cell Polarity; Cytokines; Diabetes Mellitus, Experimental; Diet, High-Fat; Fatty Acids, Nonesterified; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Macaca fascicularis; Macrophage Activation; Male; Mice; Mice, Inbred C57BL; Obesity; Phenanthrenes; RAW 264.7 Cells | 2019 |
Role of the TGFβ/p65 pathway in tanshinone ⅡA-treated HBZY‑1 cells.
Topics: Abietanes; Animals; Cell Line; Cell Proliferation; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Male; Neoplasm Proteins; Nucleocytoplasmic Transport Proteins; Rats; Rats, Sprague-Dawley; Signal Transduction; Transforming Growth Factor beta | 2014 |
Mechanisms of protection against diabetes-induced impairment of endothelium-dependent vasorelaxation by Tanshinone IIA.
Topics: Abietanes; Animals; Diabetes Mellitus, Experimental; Endothelium, Vascular; Human Umbilical Vein Endothelial Cells; Humans; Male; Nitric Oxide; Nitric Oxide Synthase Type III; Protein Phosphatase 2; Protein Transport; Rats; Rats, Sprague-Dawley; Streptozocin; Vasodilation | 2015 |
Protective effect of Tanshinone IIA on the early stage of experimental diabetic nephropathy.
Topics: Abietanes; Angiotensin II; Animals; Blood Glucose; Collagen Type IV; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enzyme-Linked Immunosorbent Assay; Glycation End Products, Advanced; Immunohistochemistry; Kidney; Macrophages; Monocytes; Neutrophil Infiltration; Phenanthrenes; Protective Agents; Proteinuria; Rats; Transforming Growth Factor beta1 | 2009 |
Tanshinone IIA pretreatment protects myocardium against ischaemia/reperfusion injury through the phosphatidylinositol 3-kinase/Akt-dependent pathway in diabetic rats.
Topics: Abietanes; Androstadienes; Animals; Anticoagulants; Apoptosis; Blotting, Western; Diabetes Mellitus, Experimental; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocytes, Cardiac; Phenanthrenes; Phosphatidylinositol 3-Kinase; Phosphorylation; Proto-Oncogene Proteins c-akt; Random Allocation; Rats; Rats, Sprague-Dawley; Signal Transduction; Wortmannin | 2010 |
Cardioprotective effects of tanshinone IIA pretreatment via kinin B2 receptor-Akt-GSK-3β dependent pathway in experimental diabetic cardiomyopathy.
Topics: Abietanes; Animals; Apoptosis; Bradykinin; Cardiomyopathies; Cardiotonic Agents; Diabetes Mellitus, Experimental; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Interleukin-6; Mitochondria, Heart; Myocardial Contraction; Myocardium; NF-kappa B; Peroxidase; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Receptor, Bradykinin B2; Signal Transduction; Stroke Volume; Tumor Necrosis Factor-alpha; Ventricular Function, Left | 2011 |